SYNOPSIS A patient with early onset myotonic dystrophy, with associated neuropathy and epilepsy, is presented. It is postulated that his disorder was inherited through a recessive, pleomorphic gene. His differential diagnosis is discussed and the literature reviewed. The clinical variability of myotonic dystrophy is stressed and the diagnostic difficulties encountered in the younger age group.
younger age group and to report associated neuropathy.
CASE REPORT K. B. was an 18 year old male who complained of progressive weakness in all limbs. His parents were unrelated and his prenatal and postnatal histories were unremarkable. His motor milestones were delayed: he was late in sitting up and in being able to lift his head off the bed; he never crawled and did not walk till the age of 2 years. He began to talk 'at the usual time'. His mother had early noted occasional twitching movements of the left eyelids.
He had been seen by a neurologist at the age of 4 years: at that time episodes of left facial twitching were reported; there was universal motor weakness, particularly involving the neck flexors; and there was generalized hypotonia and areflexia. The face was 'hatchet shaped' and there was delayed relaxation of the handgrip. At the age of 10 years he had a grand mal seizure preceded by dizziness and 'twinkling lights' in the left visual field, and was started on phenobarbitone and diphenylhydantoin. There was no family history of similar difficulties; both his parents were in good health as was one younger sister.
He was a pleasant adolescent of normal intelligence. The face was long and thin; the head scaphocephalic; the neck thin and swan-like, with extreme wasting of the sternocleidomastoid muscles ( Fig. 1 ) and marked weakness of the flexor muscles of the neck so that the head could not be lifted against gravity; the palate was high-arched and the teeth malaligned. The cardiac, respiratory, and gastro- 
DISCUSSION
The clinical and laboratory data pointed to early onset myotonic dystrophy. The clinical features were classical: the delayed milestones, hypotonia, facial spasms, poor relaxation of handgrip, weakness and wasting of neck muscles, hatchetshaped face, and high-arched palate. The EMG and muscle biopsy confirmed the diagnosis. However, the EMG study raised some questions discussed below. INHERITANCE The mode of inheritance of myotonic dystrophy is thought to be autosomal dominant (Tyler, 1954; Vanier, 1960; Caughey and Myrianthopoulos, 1963; Dodge et al., 1965; Pearson et al., 1967) . In our case, the parents and sister were studied clinically and by EMG and were normal. The inheritance is therefore presumed to be recessive; or the case may have been sporadic.
The genes transmitting the early-onset and adult types of muscular dystrophy may be different (Carter and Bundy, 1972) . The adult cases with neuropathy seen by us were sporadic (Kalyanaraman et al., 1973) . It is therefore possible that myotonic dystrophy with neuropathy differs genetically from the classical type.
NEUROPATHIC FEATURES Engel (1971) postu- lated that the peripheral nerve has an 'inhibitory' influence on myoneural function and that the loss of this inhibitory influence is manifested as myotonia. McComas et al. (1971) were of the opinion that the changes in the muscle were the result of a primary neuropathy.
In the cases of myotonia associated with neuropathy studied by Caccia et al. (1972) , there was conclusive EMG and histopathological evidence for neuropathy. The two cases of adult onset myotonic dystrophy reported by Kalyanaraman et al. (1973) showed evidence of neuropathy by EMG and muscle biopsy.
Our present patient had electromyographic evidence of neuropathy in the form of slowed motor conduction. In addition, the spinal fluid protein was elevated; an abnormality noted by Refsum et al. (1967) in nine of their 16 cases.
The question also arose whether the diphenylhydantoin he was taking for epilepsy could have been responsible for the neuropathy and the elevated spinal fluid protein. Rawson (1968) studied the spinal fluid in four patients with diphenylhydantoin intoxication: the protein was elevated in all, as was the serum level of the drug; and they all had clinical signs of cerebellar dysfunction. When, in these patients, the serum levels of the drug were lowered to the therapeutic range, the clinical signs cleared and the spinal fluid protein returned to normal. Our patient showed no clinical signs of diphenylhydantoin intoxication, and had normal serum levels of the drug. We do not think it likely, therefore, that diphenylhydantoin contributed to his neuropathy. Diphenylhydantoin, though used here for the control of seizures, has since been tried in the therapy of myotonia (Munsat, 1967) . Hence it is possible that it may have masked clinical myotonia in our patient. The raised spinal fluid protein and the neuropathy also raised the question of Landry-GuillainBarre-Strohl syndrome with reactive myotonia (Worster-Drought and Sargent, 1952) . This was unlikely in our case because of the history, clinical picture, and biopsy findings.
Multisystem involvement is known in myotonic dystrophy and there have been reports of associated hereditary neuropathy (Ziegler and Rogoff, 1956) , as well as of Charcot-MarieTooth disease (Wald et al., 1962) and of Friedreich's ataxia (Chaco and Taustein, 1969) . In all of these cases there was a strong family history. However, in our patient, the gene may have been recessive and pleomorphic, transmitting both the myotonic dystrophy and the neuropathy, without similar manifestations in other members of the family.
Epilepsy has not (as far as we are aware) been previously described as occurring in myotonic dystrophy, though non-specific changes in the EEG have been seen (Barwick et al., 1965; Watters and Williams, 1967) . Central nervous system involvement in myotonic dystrophy usually takes the form of dementia and cerebral atrophy (Refsum et al., 1967) . In our case the epilepsy may be coincidental.
In conclusion, we think our patient manifested early onset myotonic dystrophy with associated neuropathy.
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